Elsevier

Clinical Radiology

Volume 63, Issue 4, April 2008, Pages 381-386
Clinical Radiology

Increased diagnosis of pulmonary embolism without a corresponding decline in mortality during the CT era

https://doi.org/10.1016/j.crad.2007.10.004Get rights and content

Aim

To determine the association between the increasing computed tomography (CT) use for suspected pulmonary embolism (PE) on the annual rates of PE diagnosis and mortality, using time as a surrogate for CT use.

Materials and Methods

New York State's (NYS) Statewide Planning and Research Cooperative System (SPARCS) database was used to determine the rate of PE diagnosis and mortality between 1 January 1994 and 31 December 2004. Risk factors for PE were investigated. Bivariate and multivariate analyses were performed to determine the relationships between variables.

Results

The study population consisted of 24,871,131 NYS patients. The number of patients with a primary diagnosis of PE nearly doubled over the study period, from 2590 in 1994 to 4920 in 2004, while total admissions remained stable. PE deaths did not vary significantly over time, from 157 in 1994 to 159 in 2004 and did not vary with the diagnoses of PE. Age-adjusted multivariate analysis did not reveal a significant association between the rates of PE diagnosis or mortality and corresponding risk factors.

Conclusion

This study suggests that the increased use of CT in patients with suspected PE has led to an increase in the diagnosis of PE without a corresponding decline in mortality. Further evidence, using data on individual patients, is needed to determine the appropriate role of CT in evaluating patients with suspected PE.

Introduction

The incidence of pulmonary embolism (PE) in the United States is approximately one per 1000 persons per year.1 Risk factors for PE include smoking, malignancy, obesity, age, hereditary thrombophilias, prolonged immobilization, and surgery.2 Clinical signs and symptoms are notoriously nonspecific, and diagnostic and therapeutic delays are commonly cited as a major source of morbidity and mortality.2, 3

Ventilation perfusion (VQ) scintigraphy had long been the primary diagnostic test for patients with suspected PE.4, 5, 6 Although normal and high-probability VQs are believed to be diagnostic in most cases, the prospective investigation of pulmonary embolism diagnosis (PIOPED) investigation revealed that the majority of VQs fall into the intermediate or low-probability categories, with a 33 and 12% risk of PE, respectively. Combining concordant clinical suspicion with scintigraphic findings improved the diagnostic accuracy of VQ, but still established the diagnosis or exclusion of PE in only a minority of patients.5

In 1978, Sinner7 introduced the concept of using computed tomography (CT) as a diagnostic technique for suspected PE. The development of helical CT enabled imaging of the relevant anatomy in a breath-hold, leading to an interest in CT as a primary imaging test for PE.8 In 1992, Remy-Jardin et al. published the first comparison of helical CT with pulmonary angiography for the diagnosis of central PE.9 Limited resolution at the subsegmental level was an early criticism of CT in the diagnosis PE.10, 11, 12 However, interobserver reliability for pulmonary angiography is only 40–60% at the subsegmental level, making angiography an imperfect reference standard.13 Later studies investigating the safety of using a CT-based algorithm to rule out PE revealed that a negative CT is equivalent to a negative pulmonary angiogram,14, 15 with a similar risk of subsequent venous thromboembolism during follow-up. The resultant change in practice patterns has been swift and dramatic. VQ, which had constituted over 80% of the imaging for patients with suspected PE in 1979, has steadily declined, while CT, constituting significantly less than 10% of studies in the mid 1990s, surpassed VQ in 2001 as the primary imaging method.16 The development of multidetector CT machines has increased the sensitivity of CT, enabling the detection of even subsegmental emboli with a high degree of accuracy.13, 17

The traditional mainstay of therapy for PE is anticoagulation with intravenous unfractionated heparin plus an oral vitamin K antagonist.18, 19 The efficacy of heparin therapy depends upon achieving a therapeutic level within the 24 h.20 However, some patients fail to reach therapeutic levels within 24 h and some remain persistently subtherapeutic.18, 19 Low molecular weight heparins, developed in the late 1990s, have similar safety and efficacy to intravenous unfractionated heparin, but are easier to use. A fixed dose is administered subcutaneously once or twice daily.18, 21, 22, 23

Thrombolytic therapy has been introduced to treat patients with massive PE. However, its value is unproven. In meta-analysis of 748 patients from 11 clinical trials, Wan et al.24, showed no significant advantage of thrombolytic therapy over heparin with regard to recurrent PE or death. An analysis of massive PE from the International Cooperative Pulmonary Embolism Registry also did not demonstrate a reduction in mortality or recurrent PE for those treated with thrombolysis.25

The aim of this study was to determine the association between the increasing use of helical CT for suspected PE on the annual rates of PE diagnosis and PE mortality, using time as a surrogate for CT use. It was hypothesized that CT use has lead to an increase in the diagnosis of PE without an accompanying decrease in mortality.

Section snippets

Design overview

We analysed summary data from New York State's (NYS) publicly available comprehensive patient discharge dataset, the Statewide Planning and Research Cooperative System (SPARCS).26 This database combines medical records and billing files into a single all-inclusive source. All Article 28 facilities in NYS defined as hospitals, emergency departments, and ambulatory surgery centres are required to submit data to SPARCS. In addition, we obtained NYS data regarding known risk factors for PE during

Results

The SPARCS data included 24,871,131 patients from 1 January 1994 through 21 December 2004, with 1996 excluded. Among these patients, there were 692,981 deaths. A total of 34,674 patients received a primary diagnosis of PE during the study period; of these, 1537 died. The number of admissions remained relatively stable over the study period (Table 1).

Discussion

The diagnosis of PE in NYS essentially doubled from 1994–2004, while deaths in patients with PE and hospital admissions remained relatively stable. Because databases tracking CT use for suspected PE were not, to the authors' knowledge, available, the data were analysed in the context of the literature. Overall, imaging for PE has increased with the advent of helical CT, despite reductions in VQ and pulmonary angiography. Prologo et al.27 described their experience in University Hospitals in

References (37)

  • M. Remy-Jardin et al.

    Central pulmonary thromboembolism: diagnosis with spiral volumetric CT with the single breath hold technique—comparison with pulmonary angiography

    Radiology

    (1992)
  • L.R. Goodman et al.

    Detection of pulmonary embolism in patients with unresolved clinical and scintigraphic diagnosis: helical CT versus angiography

    AJR Am J Roentgenol

    (1995)
  • S.W. Rathbun et al.

    Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systematic review

    Ann Intern Med

    (2000)
  • J. Eng et al.

    Accuracy of CT in the diagnosis of pulmonary embolism: a systematic literature review

    AJR Am J Roentgenol

    (2004)
  • S.Z. Goldhaber

    Multislice computed tomography for pulmonary embolism—a technological marvel

    N Engl J Med

    (2005)
  • R. Quiroz et al.

    Clinical validity of a negative computed tomography scan in patients with suspected pulmonary embolism: a systematic review

    JAMA

    (2005)
  • A.P. Perrier et al.

    Multidetector row computed tomography in suspected pulmonary embolism

    N Engl J Med

    (2005)
  • U.J. Schoepf et al.

    Subsegmental pulmonary emboli: improved detection with thin-collimation multi-detector row spiral CT

    Radiology

    (2002)
  • Cited by (122)

    • Hospitalizations for High-Risk Pulmonary Embolism

      2021, American Journal of Medicine
      Citation Excerpt :

      Mortality was lower in high-risk patients in the Management Strategy and Prognosis of Pulmonary Embolism Registry (MAPPET), 25 of 102 (25%).16 Previous investigators suggested that the increasing incidence of pulmonary embolism in hospitalized patients relates to increased use of computed tomographic pulmonary angiography2-4 or more aggressive diagnostic testing.5 Emergency department physicians liberally, if not excessively, use computed tomographic pulmonary angiography to identify or exclude pulmonary embolism to the extent that 90%-93% are negative for pulmonary embolism.17-20

    • Higher Imaging Yield When Clinical Decision Support Is Used

      2020, Journal of the American College of Radiology
      Citation Excerpt :

      Its clinical presentation is nonspecific, and as a result, providers demonstrate a low threshold to perform advanced diagnostic imaging [6-8]. CT pulmonary angiography (CTPA) use has quadrupled over the past decade since the landmark PIOPED II trial established it as both highly sensitive and specific for the diagnosis of PE [9,10]. Increased utilization, however, has been associated with decreasing diagnostic yields and rising concerns about the harms of unnecessary testing [4,11-17].

    View all citing articles on Scopus
    View full text